Skip to main content
. 2022 Sep 16;10:1000873. doi: 10.3389/fbioe.2022.1000873

FIGURE 2.

FIGURE 2

(A) Comparison of prebiotics, probiotics, synbiotics and eLBPs. All offer promising routes for modifying the human microbiotia (B) Summary of clinical trials involving eLBPs (genetically-modified microorganisms used for a therapeutic purpose), discovered during this literature review.